Although chemotherapeutic resistance in pancreatic cancer is a serious problem and occurs through various molecular pathways [33], our data showed that FBXW7 and its substrate MCL1 are important factors involved in chemotherapeutic resistance and are expected to be candidate therapeutic targets for overcoming therapeutic resistance. The gene discussed is FBXW7; the disease is pancreatic neoplasm.